1,672
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor

, , , & ORCID Icon
Pages 1587-1598 | Received 08 Feb 2021, Accepted 13 Apr 2021, Published online: 04 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Shiliang Liu & Chenting Wen. (2022) miR-141-3p promotes retinoblastoma progression via inhibiting sushi domain-containing protein 2. Bioengineered 13:3, pages 7409-7423.
Read now
Yang Liu, Jie Liu, Junkai Cui, Ruolei Zhong & Guoyang Sun. (2022) Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis. Bioengineered 13:1, pages 1115-1125.
Read now
Dehong Mao, Zhongmei He, Wei Xuan, Jiao Deng, Weichun Li, Xiaoying Fang, Linglong Li & Feng Zhang. (2021) Effect and mechanism of BDNF/TrkB signaling on vestibular compensation. Bioengineered 12:2, pages 11823-11836.
Read now
Ke Shi, Xinyue Zhu, Jiali Wu, Yuhong Chen, Jingfa Zhang & Xiaodong Sun. (2021) Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma. Bioengineered 12:1, pages 5950-5970.
Read now

Articles from other publishers (8)

Aeshah Alluli, Willem Rijnbout St. James, David H. Eidelman & Carolyn J. Baglole. (2023) Dynamic relationship between the aryl hydrocarbon receptor and long noncoding RNA balances cellular and toxicological responses. Biochemical Pharmacology 216, pages 115745.
Crossref
M. A. Nikitina, V. M. Alifirova, S. O. Borodina & E. S. Koroleva. (2023) Markers of Neurodegeneration in Parkinson’s Disease. Neurochemical Journal 17:3, pages 338-348.
Crossref
Maryam Farzaneh, Ava Nasrolahi, Farhoodeh Ghaedrahmati, Tariq Masoodi, Sajad Najafi, Mohadeseh Sheykhi-Sabzehpoush, Mahrokh Abouali Gale Dari, Klaudia Radoszkiewicz, Shahab Uddin, Shirin Azizidoost & Seyed Esmaeil Khoshnam. (2023) Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells. Clinical and Translational Oncology 25:7, pages 2015-2042.
Crossref
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz, Sajad Najafi, Farhoodeh Ghaedrahmati, Mohadeseh Sheykhi-Sabzehpoush, Jafar Poodineh, Maryam Hajizadeh, Amir Anbiyaiee, Maryam Farzaneh & Mostafa Feghhi. (2022) Long non-coding RNAs involved in retinoblastoma. Journal of Cancer Research and Clinical Oncology 149:1, pages 401-421.
Crossref
Nasrin Ahangar Davoodi, Sajad Najafi, Zari Naderi Ghale-Noie, Ashkan Piranviseh, Samaneh Mollazadeh, Sahar Ahmadi Asouri, Zatollah Asemi, Mohammadamin Morshedi, Seyed Saeed Tamehri Zadeh, Michael R. Hamblin, Amirhossein Sheida & Hamed Mirzaei. (2022) Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. Frontiers in Cell and Developmental Biology 10.
Crossref
Wei Han, Chun-tao Shi, Jun Ma, Hua Chen, Qi-xiang Shao, Xiao-jiao Gao, Ying Zhou, Jing-feng Gu & Hao-nan Wang. (2022) Pan-cancer analysis of LncRNA XIST and its potential mechanisms in human cancers. Heliyon 8:10, pages e10786.
Crossref
Xiumei He & Yueyue Feng. (2022) MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression. Anti-Cancer Drugs 33:5, pages 478-488.
Crossref
Chiara Siniscalchi, Armando Di Palo, Aniello Russo & Nicoletta Potenza. (2022) The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation. International Journal of Molecular Sciences 23:2, pages 611.
Crossref